Effect of Linker-Drug Properties and Conjugation Site on the Physical Stability of ADCs
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 109 (5) , 1662-1672
Abstract
No abstract availableKeywords
Funding Information
- AbbVie
This publication has 47 references indexed in Scilit:
- A Case Study Comparing Heterogeneous Lysine- and Site-Specific Cysteine-Conjugated Maytansinoid Antibody-Drug Conjugates (ADCs) Illustrates the Benefits of Lysine ConjugationMolecular Pharmaceutics, 2019
- In-Depth Comparison of Lysine-Based Antibody-Drug Conjugates Prepared on Solid Support Versus in SolutionAntibodies, 2018
- Characterization and Higher-Order Structure Assessment of an Interchain Cysteine-Based ADC: Impact of Drug Loading and Distribution on the Mechanism of AggregationBioconjugate Chemistry, 2016
- A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatographymAbs, 2015
- Statistics of the Distribution of the Abundance of Molecules with Various Drug Loads in Maytansinoid Antibody–Drug ConjugatesMolecular Pharmaceutics, 2015
- Auristatin Antibody Drug Conjugate Physical Instability and the Role of Drug PayloadBioconjugate Chemistry, 2014
- Investigation into Temperature-Induced Aggregation of an Antibody Drug ConjugateBioconjugate Chemistry, 2013
- Physicochemical Stability of the Antibody−Drug Conjugate Trastuzumab-DM1: Changes due to Modification and Conjugation ProcessesBioconjugate Chemistry, 2010
- Structural characterization of the maytansinoid–monoclonal antibody immunoconjugate, huN901–DM1, by mass spectrometryProtein Science, 2005
- Mass Spectral Analyses of Labile DOTA-NHS and Heterogeneity Determination of DOTA or DM1 Conjugated Anti-PSMA Antibody for Prostate Cancer TherapyJournal of Pharmaceutical Sciences, 2005